España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Ayala Pharmaceuticals
ADXS
OTCEM
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Ayala Pharmaceuticals (ADXS) Forecast
News
Earnings
Ayala Pharmaceuticals (ADXS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Ayala Pharmaceuticals (OTC:ADXS) Stock
Ayala Pharmaceuticals Stock (OTC: ADXS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, February 20, 2024
Immunome Recognizes Ayala Pharmaceuticals' An...
Benzinga Newsdesk
Thursday, November 16, 2023
Ladenburg Thalmann Downgrades Ayala Pharmaceu...
Benzinga Newsdesk
Tuesday, May 30, 2023
Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023
Benzinga Insights
Ladenburg Thalmann Upgrades Advaxis to Buy, A...
Benzinga Newsdesk
Wednesday, October 19, 2022
Ayala Pharmaceuticals and Advaxis Agree To Combine, Expect Uplisting On NASDAQ
Vandana Singh
Advaxis and Ayala Pharmaceuticals Enter into Merger Agreement in All-Stock Deal
Charles Gross
Thursday, May 12, 2022
Advaxis Says Applied To List Common Stock On ...
Benzinga Newsdesk
Wednesday, April 27, 2022
Several Companies Highlight Upcoming Presenta...
Benzinga Newsdesk
Tuesday, January 11, 2022
Advaxis Highlights Presentation Of Updated Clinical Data From Ongoing Phase 1/2 Trial Of ADXS-503 In NSCLC And Upcoming Milestones
Bill Haddad
Wednesday, December 22, 2021
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Friday, December 17, 2021
Advaxis Reports Will Explore Added Options To...
Benzinga Newsdesk
Friday, December 10, 2021
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Tuesday, November 30, 2021
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Wednesday, November 24, 2021
Advaxis Issues Letter, Second Video Message T...
Benzinga Newsdesk
Tuesday, November 23, 2021
Advaxis Granted U.S. Patent #11,179,339 'Compositions and methods for lyophilization of bacteria or listeria strains'
Charles Gross
Friday, November 19, 2021
Advaxis, Inc. Issues Letter to Stockholders
Bill Haddad
Thursday, November 18, 2021
Independent Proxy Advisory Firm Glass Lewis J...
Benzinga Newsdesk
Friday, November 12, 2021
Top 10 WallStreetBets Stock Mentions In Pre-M...
Charles Gross
Thursday, September 30, 2021
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Thursday, September 16, 2021
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Tuesday, September 14, 2021
72 Biggest Movers From Yesterday
Lisa Levin
Monday, September 13, 2021
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
45 Stocks Moving In Monday's Mid-Day Session
Lisa Levin
21 Stocks Moving in Monday's Pre-Market Session
Lisa Levin
Friday, September 10, 2021
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Advaxis shares are trading higher after the c...
Benzinga Newsdesk
Advaxis Earnings Perspective: Return On Capital Employed
Benzinga Insights
Advaxis Q3 EPS $(0.02) Beats $(0.04) Estimate...
Benzinga Newsdesk
Tuesday, September 07, 2021
53 Biggest Movers From Friday
Lisa Levin
Friday, September 03, 2021
35 Stocks Moving In Friday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
20 Stocks Moving in Friday's Pre-Market Session
Lisa Levin
Friday, August 27, 2021
63 Biggest Movers From Yesterday
Lisa Levin
Thursday, August 26, 2021
45 Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
22 Stocks Moving in Thursday's Pre-Market Session
Lisa Levin
Wednesday, August 25, 2021
Advaxis S-4 Filing Out Related To Proposed Merger Between Advaxis, Biosight
Michael Horton
Wednesday, August 11, 2021
Nasdaq Grants Advaxis, Inc. an Extension to N...
Benzinga Newsdesk
Thursday, July 15, 2021
Advaxis Kick Starts Early-Stage Study For Prostate Cancer Immunotherapy
Vandana Singh
Advaxis Announces Initiation Of Phase 1 Clini...
Bill Haddad
Wednesday, July 14, 2021
Advaxis To Present At The Non-Small Cell Lung Cancer Drug Development Summit Jul. 15
Bill Haddad
Wednesday, July 07, 2021
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
61 Biggest Movers From Yesterday
Lisa Levin
Tuesday, July 06, 2021
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Mid-Afternoon Market Update: Dow Tumbles 300 Points; Advaxis Shares Spike Higher
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Mid-Day Market Update: Gold Rises Over 1%; Provention Bio Shares Plunge
Lisa Levin
42 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Why Odonate Therapeutics, Opthea, ALX Oncology, Advaxis and Provention Bio Are Moving Today
Shanthi Rexaline
Show More